PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 4, 2022
Aquestive Therapeutics, Inc.
(Exact name of Registrant as specified in its charter)
30 Technology Drive
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
(Former name or former address, if changed since last report)
On November 4, 2022, Aquestive Therapeutics, Inc. (the “Company”) issued a notice of partial redemption (the “Notice of Partial
Redemption”) pursuant to the indenture, dated as of July 15, 2021 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) as trustee and collateral agent
governing its 12.5% Senior Secured Notes due 2025 (the “Notes”).
Pursuant to the Notice of Partial Redemption, the Company gave holders of the Notes notice that it intends to redeem $3,765,000 of its
outstanding Notes on January 3, 2023 at a redemption price that will be calculated pursuant to the formula set forth in the Indenture governing the Notes, plus accrued and unpaid interest.
This Current Report on Form 8-K should not be construed as a notice of redemption for any of the outstanding Notes.
This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include, without limitation, statements regarding our expectations, hopes or intentions regarding the future. These forward looking statements can often be
identified by their use of words such as “will”, “predict”, “continue”, “forecast”, “expect”, “believe”, “anticipate”, “outlook”, “could”, “target”, “project”, “intend”, “plan”, “seek”, “estimate”, “should”, “may” and “assume”, as well as
variations of such words and similar expressions referring to the future, and may include (without limitation) statements regarding the terms and conditions and timing of the Notes redemption. Forward-looking statements involve certain risks and
uncertainties, and actual results may differ materially from those discussed in each such statement. Factors that could cause actual results to differ include (without limitation) the possibility that the Notes redemption will not be consummated at
the expected time, on the expected terms, or at all; and the Company’s financial performance. Additional factors are discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021
and in the Company’s other current and periodic reports filed from time to time with the Securities and Exchange Commission. All forward-looking statements in this document are made based on information available to the Company as of the date
hereof, and the Company assumes no obligation to update any forward-looking statement.